Ritholtz Wealth Management Gilead Sciences, Inc. Transaction History

Ritholtz Wealth Management

$2.87 Billion
Q1 2024

A detailed history of Ritholtz Wealth Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ritholtz Wealth Management holds 59,954 shares of GILD stock, worth $4 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

59,954

Previous 64,042 6.38%

Holding current value

$4 Million

Previous $5.19 Million 15.36%

% of portfolio

0.15%

Previous 0.2%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$71.58 - $87.29 $292,619 - $356,841	-4,088 Reduced 6.38%	59,954 $4.39 Million
Q4 2023 Jan 18, 2024	BUY	$73.27 - $83.09 $121,628 - $137,929	1,660 Added 2.66%	64,042 $5.19 Million
Q3 2023 Oct 13, 2023	SELL	$73.94 - $80.67 $102,776 - $112,131	-1,390 Reduced 2.18%	62,382 $4.67 Million
Q2 2023 Jul 14, 2023	SELL	$76.01 - $86.7 $130,205 - $148,517	-1,713 Reduced 2.62%	63,772 $4.91 Million
Q1 2023 Apr 19, 2023	SELL	$77.31 - $88.08 $229,842 - $261,861	-2,973 Reduced 4.34%	65,485 $5.43 Million

Q4 2022 Jan 18, 2023	BUY	$62.32 - $89.47 $612,730 - $879,669	9,832 Added 16.77%	68,458 $0
Q3 2022 Oct 18, 2022	BUY	$59.54 - $68.01 $2.97 Million - $3.39 Million	49,837 Added 567.04%	58,626 $3.62 Million
Q2 2022 Jul 15, 2022	BUY	$57.72 - $65.01 $130,389 - $146,857	2,259 Added 34.59%	8,789 $543,000
Q1 2022 Apr 14, 2022	SELL	$57.92 - $72.58 $189,745 - $237,772	-3,276 Reduced 33.41%	6,530 $388,000
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $65,723 - $74,597	1,013 Added 11.52%	9,806 $712,000
Q3 2021 Oct 14, 2021	BUY	$67.69 - $73.03 $56,656 - $61,126	837 Added 10.52%	8,793 $614,000
Q2 2021 Jul 20, 2021	SELL	$63.47 - $69.35 $3,617 - $3,952	-57 Reduced 0.71%	7,956 $548,000
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $480,780 - $548,569	8,013 New	8,013 $518,000
Q4 2020 Jan 19, 2021	SELL	$56.65 - $64.55 $218,499 - $248,969	-3,857 Closed	0 $0
Q3 2020 Oct 23, 2020	SELL	$62.1 - $78.08 $12,420 - $15,616	-200 Reduced 4.93%	3,857 $244,000
Q2 2020 Jul 15, 2020	BUY	$72.34 - $84.0 $82,033 - $95,256	1,134 Added 38.8%	4,057 $312,000
Q1 2020 Apr 09, 2020	BUY	$62.63 - $80.22 $183,067 - $234,483	2,923 New	2,923 $219,000
Q3 2019 Oct 17, 2019	SELL	$62.51 - $69.0 $221,973 - $245,019	-3,551 Closed	0 $0
Q2 2019 Jul 15, 2019	SELL	$61.87 - $69.38 $66,510 - $74,583	-1,075 Reduced 23.24%	3,551 $240,000
Q1 2019 Apr 12, 2019	SELL	$62.53 - $70.05 $21,260 - $23,817	-340 Reduced 6.85%	4,626 $301,000
Q4 2018 Jan 18, 2019	SELL	$60.54 - $79.0 $30,814 - $40,211	-509 Reduced 9.3%	4,966 $311,000
Q3 2018 Oct 12, 2018	SELL	$71.28 - $78.92 $82,043 - $90,836	-1,151 Reduced 17.37%	5,475 $423,000
Q2 2018 Jul 12, 2018	SELL	$64.88 - $75.68 $155,647 - $181,556	-2,399 Reduced 26.58%	6,626 $469,000
Q1 2018 Apr 17, 2018	SELL	$72.84 - $88.8 $249,477 - $304,140	-3,425 Reduced 27.51%	9,025 $680,000
Q4 2017 Jan 23, 2018	BUY	$71.15 - $83.52 $885,817 - $1.04 Million	12,450	12,450 $892,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Ritholtz Wealth Management with notifications on news.

Account

Ritholtz Wealth Management Gilead Sciences, Inc. Transaction History